Antihypertensive AgentsNCT07858695
Barber and Pharmacist Coordination to Improve Blood Pressure Management
A study testing Telemedicine Barbershop BP Reduction in people with Antihypertensive Agents and High Blood Pressure, run by Cedars-Sinai Medical Center at 1 site in United States.
Trial summary
The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its… Read more about this study
- Who is it for?
- Ages 35 to 79 years, men only
- Conditions the study is for
- Antihypertensive Agents, High Blood Pressure, Hypertension
- What is being tested?
- Telemedicine Barbershop BP Reduction
- How many people
- 55 participants
- Where
- 1 siteUnited States
- Study dates
- 31 Oct 2026to 30 Apr 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 79 years
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Ages 35-79
- Self-identify as NH Black male
- Documented systolic BP ≥ 140 mmHg on 2 or more separate screening days. The second BP assessment must be completed within a 4-week period
- Regularly attend the same barbershop (barbershop patrons having at least one haircut every 6 weeks in the same barbershop for the past 6 months)
- Signed physician collaborative practice agreement with the study pharmacist
Who cannot join
- Ages <35 or >79 years
- Arm circumference incompatible with the BP device
- Severe cognitive impairment
- Non-fluent in English
- Currently receiving chemotherapy for cancer
- Current or planned cardiac, renal, or liver transplant
Show all 11Show fewer
- Currently receiving dialysis
- New/infrequent patronage (<8 haircuts at the same barbershop in the past 12 months)
- Plans to move/relocate in the next 12 months and/or travel out-of-area for > 1 month
- Participation in a clinical trial where the active treatment study is testing a BP agent and/or intervention
- Unwilling or unable to provide informed consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Cedars-Sinai Medical Center
Los Angeles, California, 90048
Ciantel Adair Blyler, PharmaD, 310-248-7520, ciantel.blyler@cshs.org
About this study
The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged. The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men." It will build upon the foundational work of the original study and telemedicine pilot by evaluating the efficacy of a fully remote hypertension management program.
Read the detailed description
The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged.
The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men". The goal of the study is to build upon the foundational work of the original study and adapt the in-person clinical pharmacist-led LABBPS hypertension (HTN) management program into a complete telemedicine version and assess feasibility, acceptability, effectiveness, and implementation considerations of the adaptation to inform future scale-up. We will design and test the impact of barber assisted hypertension screening combined with clinical pharmacist-led hypertension management delivered via a secure video platform among 55 men from 10 barbershops. Participants will be age 35-79 years with stage 2 hypertension defined as systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg. This diverse age group was chosen because current guidelines recommend initiation of antihypertensive medications for stage 2 hypertension regardless of baseline cardiovascular risk. In addition to using validated implementation science frameworks to measure feasibility and acceptability, the study will also quantify effectiveness by comparing changes in blood pressure at 6-months to those achieved in the original in-person intervention.
Hypertension (HTN) is an exceptionally common condition that imposes a substantial public health burden and disproportionately impacts non-Hispanic (NH) Black men. The Barber and Pharmacist Coordination to Improve Blood Pressure Management Study builds upon the foundational work of the Los Angeles Barbershop BP Study (ClinicalTrials.gov ID: NCT02321618) and seeks to develop a less costly and more convenient telemedicine version of pharmacist-driven, community-based hypertension care for black men that will enable widespread adoption of this healthcare model across barbershops nationwide. While the barbershop-based approach has demonstrated success in non-Hispanic black men, the benefits may well extend to other racial and ethnic populations who frequent community- based venues. Increasing adoption of community-based interventions and enabling supportive healthcare policies requires the demonstration of a financially feasible model and durable impact on clinical outcomes.
- Conditions
- Antihypertensive Agents, High Blood Pressure, Hypertension
- Being tested
- Telemedicine Barbershop BP Reduction
- Keywords
- Barbershop, Pharmacist, African American Men, High Blood Pressure, Hypertension, Telemedicine, Team-Based Care
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Telemedicine Barbershop BP ReductionOther
Test feasibility, acceptability, and effectiveness of an adapted blood pressure reduction intervention that moves the LABBPS in-person clinical pharmacist to a telemedicine platform inside of the barbershop.
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Systolic Blood Pressure (SBP)
The primary outcome will be the difference in SBP measured at 6 months compared to enrollment.
Measured: 6 months
Secondary outcomes (1)
Change in Diastolic Blood Pressure (DBP)
- Difference in DBP measured at 6 months compared to enrollment
- Achievement of goal BP, 6 months, Proportion of participants achieving SBP <130 mm Hg AND DBP <80 mm Hg
- Medication Intensification, 6 months, Difference in the number of BP drugs of different classes at 6 months compared to enrollment
- First-line medication use, 6 months, Difference in percentage of participants receiving first-line BP drug classes at 6 months compared to enrollment
- Recruitment and retention rates will be quantified to assess feasibility
- Acceptability to barbers and participants
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Oct 2026
- Study start31 Oct 2026 (estimated)
- Primary completion31 Oct 2028 (estimated)
- Study completion30 Apr 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Antihypertensive AgentsStudies of the same condition, open and under way.
- More trials run by Cedars-Sinai Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 55 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cedars-Sinai Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- National Institutes of Health (NIH), National Institute on Minority Health and Health Disparities (NIMHD)
- Responsible party
- Principal investigator, Christine Albert, Cedars-Sinai Medical Center
- Investigators
- Christine Albert, MD, MPH, Principal investigator, Brigham and Women's Hosptial
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07858695
- Sponsor's protocol ID
- Pro00054480
- Other IDs
- R01MD019502
- Status last verified
- Sep 2026
- First submitted
- 29 Sep 2026
- Last updated
- 5 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, Brettler J, Rashid M, Hsu B, Foxx-Drew D, Moy N, Reid AE, Elashoff RM. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018 Apr 5;378(14):1291-1301. doi: 10.1056/NEJMoa1717250. Epub 2018 Mar 12.
PubMed 29527973Victor RG, Blyler CA, Li N, Lynch K, Moy NB, Rashid M, Chang LC, Handler J, Brettler J, Rader F, Elashoff RM. Sustainability of Blood Pressure Reduction in Black Barbershops. Circulation. 2019 Jan 2;139(1):10-19. doi: 10.1161/CIRCULATIONAHA.118.038165.
PubMed 30592662Blyler CA, Rader F. Sustainability of blood pressure reduction in black barbershops. Curr Opin Cardiol. 2019 Nov;34(6):693-699. doi: 10.1097/HCO.0000000000000674.
PubMed 31425171Blyler CA, Ebinger J, Rashid M, Moy NP, Cheng S, Albert CM, Rader F. Improving Efficiency of the Barbershop Model of Hypertension Care for Black Men With Virtual Visits. J Am Heart Assoc. 2021 Jul 6;10(13):e020796. doi: 10.1161/JAHA.120.020796. Epub 2021 Jun 22.
PubMed 34155907Bryant KB, Moran AE, Kazi DS, Zhang Y, Penko J, Ruiz-Negron N, Coxson P, Blyler CA, Lynch K, Cohen LP, Tajeu GS, Fontil V, Moy NB, Ebinger JE, Rader F, Bibbins-Domingo K, Bellows BK. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops. Circulation. 2021 Jun 15;143(24):2384-2394. doi: 10.1161/CIRCULATIONAHA.120.051683. Epub 2021 Apr 15.
PubMed 33855861Kazi DS, Wei PC, Penko J, Bellows BK, Coxson P, Bryant KB, Fontil V, Blyler CA, Lyles C, Lynch K, Ebinger J, Zhang Y, Tajeu GS, Boylan R, Pletcher MJ, Rader F, Moran AE, Bibbins-Domingo K. Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value. Circulation. 2021 Jun 15;143(24):2406-2408. doi: 10.1161/CIRCULATIONAHA.120.051782. Epub 2021 Jun 14. No abstract available.
PubMed 34125566
Study at a glance
From the registry record, last updated by the sponsor on 5 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Barber and Pharmacist Coordination to Improve Blood Pressure Management
- ClinicalTrials.gov ID
- NCT07858695
- Acronym / sponsor ID
- Pro00054480
- Conditions
- Antihypertensive Agents, High Blood Pressure, Hypertension
- Keywords
- Barbershop, Pharmacist, African American Men, High Blood Pressure, Hypertension, Telemedicine, Team-Based Care
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 55 participants (estimated)
- Lead sponsor
- Cedars-Sinai Medical CenterUniversity, hospital or other
- Collaborators
- National Institutes of Health (NIH), National Institute on Minority Health and Health Disparities (NIMHD)
- Study start
- 31 Oct 2026 (estimated)
- Primary completion
- 31 Oct 2028 (estimated)
- Study completion
- 30 Apr 2029 (estimated)
- First posted
- 5 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged. The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men." It will build upon the foundational work of the original study and telemedicine pilot by evaluating the efficacy of a fully remote hypertension management program.
Detailed description
The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged.
The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men". The goal of the study is to build upon the foundational work of the original study and adapt the in-person clinical pharmacist-led LABBPS hypertension (HTN) management program into a complete telemedicine version and assess feasibility, acceptability, effectiveness, and implementation considerations of the adaptation to inform future scale-up. We will design and test the impact of barber assisted hypertension screening combined with clinical pharmacist-led hypertension management delivered via a secure video platform among 55 men from 10 barbershops. Participants will be age 35-79 years with stage 2 hypertension defined as systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg. This diverse age group was chosen because current guidelines recommend initiation of antihypertensive medications for stage 2 hypertension regardless of baseline cardiovascular risk. In addition to using validated implementation science frameworks to measure feasibility and acceptability, the study will also quantify effectiveness by comparing changes in blood pressure at 6-months to those achieved in the original in-person intervention.
Hypertension (HTN) is an exceptionally common condition that imposes a substantial public health burden and disproportionately impacts non-Hispanic (NH) Black men. The Barber and Pharmacist Coordination to Improve Blood Pressure Management Study builds upon the foundational work of the Los Angeles Barbershop BP Study (ClinicalTrials.gov ID: NCT02321618) and seeks to develop a less costly and more convenient telemedicine version of pharmacist-driven, community-based hypertension care for black men that will enable widespread adoption of this healthcare model across barbershops nationwide. While the barbershop-based approach has demonstrated success in non-Hispanic black men, the benefits may well extend to other racial and ethnic populations who frequent community- based venues. Increasing adoption of community-based interventions and enabling supportive healthcare policies requires the demonstration of a financially feasible model and durable impact on clinical outcomes.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 35 to 79 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Ages 35-79
- Self-identify as NH Black male
- Documented systolic BP ≥ 140 mmHg on 2 or more separate screening days. The second BP assessment must be completed within a 4-week period
- Regularly attend the same barbershop (barbershop patrons having at least one haircut every 6 weeks in the same barbershop for the past 6 months)
- Signed physician collaborative practice agreement with the study pharmacist
Key exclusion criteria (11 listed)
- Ages <35 or >79 years
- Arm circumference incompatible with the BP device
- Severe cognitive impairment
- Non-fluent in English
- Currently receiving chemotherapy for cancer
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Telemedicine Barbershop BP ReductionTest feasibility, acceptability, and effectiveness of an adapted blood pressure reduction intervention that moves the LABBPS in-person clinical pharmacist to a telemedicine platform inside of the barbershop. | Other | – |
Primary outcome
Change in Systolic Blood Pressure (SBP)
Time frame: 6 months
The primary outcome will be the difference in SBP measured at 6 months compared to enrollment.
1 secondary outcome
Change in Diastolic Blood Pressure (DBP)
Time frame: 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Oct 2026.
- Results publication: PubMed 29527973Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, Brettler J, Rashid M, Hsu B, Foxx-Drew D, Moy N, Reid AE, Elashoff RM. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018 Apr 5;378(14):1291-1301. doi: 10.1056/NEJMoa1717250. Epub 2018 Mar 12.
- Results publication: PubMed 30592662Victor RG, Blyler CA, Li N, Lynch K, Moy NB, Rashid M, Chang LC, Handler J, Brettler J, Rader F, Elashoff RM. Sustainability of Blood Pressure Reduction in Black Barbershops. Circulation. 2019 Jan 2;139(1):10-19. doi: 10.1161/CIRCULATIONAHA.118.038165.
- Results publication: PubMed 31425171Blyler CA, Rader F. Sustainability of blood pressure reduction in black barbershops. Curr Opin Cardiol. 2019 Nov;34(6):693-699. doi: 10.1097/HCO.0000000000000674.
- Results publication: PubMed 34155907Blyler CA, Ebinger J, Rashid M, Moy NP, Cheng S, Albert CM, Rader F. Improving Efficiency of the Barbershop Model of Hypertension Care for Black Men With Virtual Visits. J Am Heart Assoc. 2021 Jul 6;10(13):e020796. doi: 10.1161/JAHA.120.020796. Epub 2021 Jun 22.
- Results publication: PubMed 33855861Bryant KB, Moran AE, Kazi DS, Zhang Y, Penko J, Ruiz-Negron N, Coxson P, Blyler CA, Lynch K, Cohen LP, Tajeu GS, Fontil V, Moy NB, Ebinger JE, Rader F, Bibbins-Domingo K, Bellows BK. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops. Circulation. 2021 Jun 15;143(24):2384-2394. doi: 10.1161/CIRCULATIONAHA.120.051683. Epub 2021 Apr 15.
- Results publication: PubMed 34125566Kazi DS, Wei PC, Penko J, Bellows BK, Coxson P, Bryant KB, Fontil V, Blyler CA, Lyles C, Lynch K, Ebinger J, Zhang Y, Tajeu GS, Boylan R, Pletcher MJ, Rader F, Moran AE, Bibbins-Domingo K. Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value. Circulation. 2021 Jun 15;143(24):2406-2408. doi: 10.1161/CIRCULATIONAHA.120.051782. Epub 2021 Jun 14. No abstract available.
- Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study - ClinicalTrials.govLink provided by the sponsor.
- Cut Your Pressure 3 - ClinicalTrials.govLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Antihypertensive Agents
Not yet recruitingPhase 2
A Study Evaluating the Efficacy and Safety of SYH2072 Tablets In Hypertensive Patients
Uncontrolled Hypertension, Resistant Hypertension
RecruitingObservational study
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
RecruitingPhase 4
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
Cerebrovascular Disorders
Enrolling by invitationObservational study
Heart Rate Variability and Medication Adherence in Resistant Hypertension
Resistant Hypertension, Medication Adherence
Recruiting
IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Control in Non-adherent Hypertensive Patients
Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Christine Albert, MD, MPH principal investigator
Brigham and Women's Hosptial
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Telemedicine Barbershop BP Reduction in people with Antihypertensive Agents and High Blood Pressure, run by Cedars-Sinai Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ciantal Adair Blyler, PharmD (310-248-7520, ciantel.blyler@cshs.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Systolic Blood Pressure (SBP) (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07858695, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.